Evidence map›Paper›PMID 29779173›Full record

ArticleMolecular neurobiology2019

Long Lasting High Lysine Diet Aggravates White Matter Injury in Glutaryl-CoA Dehydrogenase Deficient (Gcdh-/-) Mice.

Silvia Olivera-Bravo, Bianca Seminotti, Eugenia Isasi, César A Ribeiro, Guilhian Leipnitz, Michael Woontner, Stephen I Goodman, Diogo Souza, Luis Barbeito, Moacir Wajner

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Therapeutic AASS inhibition by AAV-miRNA rescues glutaric aciduria type I severe phenotype in mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Neurological manifestations of organic acidurias.Nature reviews. Neurology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Silvia Olivera-BravoNeurobiología Celular y Molecular, IIBCE, CIP 11600, Montevideo, Uruguay. solivera@iibce.edu.uy.ORCID http://orcid.org/0000-0002-6483-1466
Bianca SeminottiDepartamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, CEP 900035-003, Brazil.
Eugenia IsasiNeurobiología Celular y Molecular, IIBCE, CIP 11600, Montevideo, Uruguay.
César A RibeiroNatural and Humanities Sciences Center, Federal University of ABC (UFABC), São Bernardo do Campo, SP, 09606-070, Brazil.
Guilhian LeipnitzDepartamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, CEP 900035-003, Brazil.
Michael WoontnerDepartment of Pediatrics, Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, 97239, USA.
Stephen I GoodmanDepartment of Pediatrics, Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, 97239, USA.
Diogo SouzaDepartamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, CEP 900035-003, Brazil.
Luis BarbeitoInstitut Pasteur Montevideo, Mataojo 2020, CIP 11400, Montevideo, Uruguay.
Moacir WajnerDepartamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, CEP 900035-003, Brazil.
Universidade Federal do Rio Grande do Sul · BRInstituto de Investigaciones Biológicas Clemente Estable · UYOregon Health & Science University · USInstitut Pasteur de Montevideo · UYUniversidade Federal do ABC · BR

Funding

ANII Beca doctorado EICNPQ (CNPq) - 470236/2012-4FAPERGS 10/0031-1IBN-Net # 01.06.0842-00INCT-EN 573677/2008-5PEDECIBA Biología SOlivera2017PROPESQ/UFRGS PIBIT 18489
6 · The paper itself

Abstract

Glutaric acidemia type I (GA-I) is a neurometabolic disease caused by deficient activity of glutaryl-CoA dehydrogenase (GCDH) that results in accumulation of metabolites derived from lysine (Lys), hydroxylysine, and tryptophan catabolism. GA-I patients typically develop encephalopatic crises with striatal degeneration and progressive white matter defects. However, late onset patients as well as Gcdh-/- mice only suffer diffuse myelinopathy, suggesting that neuronal death and white matter defects are different pathophysiological events. To test this hypothesis, striatal myelin was studied in Gcdh-/- mice fed from 30 days of age during up to 60 days with a diet containing normal or moderately increased amounts of Lys (2.8%), which ensure sustained elevated levels of GA-I metabolites. Gcdh-/- mice fed with 2.8% Lys diet showed a significant decrease in striatal-myelinated areas and progressive vacuolation of white matter tracts, as compared with animals fed with normal diet. Myelin pathology increased with the time of exposure to high Lys diet and was also detected in 90-day old Gcdh-/- mice fed with normal diet, suggesting that dietary Lys accelerated the undergoing white matter damage. Gcdh-/- mice fed with 2.8% Lys diet also showed increased GRP78/BiP immunoreactivity in oligodendrocytes and neurons, denoting ER stress. However, the striatal and cortical neuronal density was unchanged with respect to normal diet. Thus, myelin damage seen in Gcdh-/- mice fed with 2.8% Lys seems to be mediated by a long-term increased levels of GA-I metabolites having deleterious effects in myelinating oligodendrocytes over neurons.

Indexed as

DietAnimalsCell CountCell DeathCorpus StriatumEndoplasmic Reticulum Chaperone BiPGlutaryl-CoA DehydrogenaseLysineMiceMyelin SheathNeuronsOligodendrogliaWhite MatterEndoplasmic Reticulum Chaperone BiPGlutaryl-CoA DehydrogenaseHspa5 protein, mouseLysineGcdh−/− miceGlutaric acidemia type ILysine overdoseMyelin alterations

Identifiers

PMID29779173
OpenAlexW2804013686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.